<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Clinical trial indicates Denamarin may act as hepatoprotectant </title><link>/b/veterinary-news/posts/8080</link><description> Protexin has announced that preliminary data from a clinical trial supports the use of Denamarin &amp;#174; to protect against lomustine (CCNU)-induced hepatotoxicity in dogs. 
 The study is being performed at the University of California-Davis, Veterinary Medical</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>